Home › NDC Lookup › RxCUI directory › RxCUI 352213

Treprostinil 5 MG/ML Injectable Solution [Remodulin] — RxCUI 352213

Name: Treprostinil 5 MG/ML Injectable Solution [Remodulin] (RxCUI 352213)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 352213 Semantic branded drug · SBD ● Current RxNorm concept 6 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI352213

Official nameTreprostinil 5 MG/ML Injectable Solution [Remodulin]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asRemodulin 5 MG/ML Injectable Solution

FDA products mapped6

Package NDCs mapped6

Reported Medicaid activity (SDUD)7,471 prescriptions · 35 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Treprostinil Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Treprostinil injection — sold as Remodulin — is used to treat pulmonary arterial hypertension, or PAH. That's a condition where the blood pressure inside the arteries leading to yo...
What exactly is treprostinil injection used for?
No — treprostinil injection is given as a continuous infusion that runs around the clock, usually through a small pump you wear. Most people receive it through a tiny catheter plac...
How is this medication given? Do I have to go to a clinic for every dose?

📖 Read our full Treprostinil Injection guide →

🕸️ Concept Web — How Treprostinil 5 MG/ML Injectable Solution [Remodu... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Treprostinil 5 MG/ML Injectable Solution [Remodulin] RxCUI 352213 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Treprostinil 343048 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Remodulin 323640 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Treprostinil Injectable Solution 385082 SCDF
- Treprostinil Injectable Product 1157682 SCDG
- Treprostinil Injectable Solution [Remodulin] 402707 SBDF
- Remodulin Injectable Product 1180729 SBDG
- Injectable Solution 316949 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Treprostinil 5 MG/ML Injectable Solution 349410 SCD
- Treprostinil 5 MG/ML 384952 SCDC
- Treprostinil 5 MG/ML [Remodulin] 575935 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Treprostinil 5 MG/ML Injectable Solution SCD · 349410
Treprostinil 5 MG/ML SCDC · 384952
Treprostinil Injectable Solution SCDF · 385082
Treprostinil Injectable Product SCDG · 1157682

Brand-Name Concepts

Treprostinil 5 MG/ML [Remodulin] SBDC · 575935
Treprostinil Injectable Solution [Remodulin] SBDF · 402707
Remodulin Injectable Product SBDG · 1180729
Remodulin BN · 323640

📦 FDA Products & Package NDCs

6 products · 6 package NDCs

6 package NDCs map to RxCUI 352213 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
66302-0101-01	1 VIAL in 1 BOX (66302-101-01) / 20 mL in 1 VIAL	Remodulin	United Therapeutics Corporation	2002-05-22
66302-0102-01	1 VIAL in 1 BOX (66302-102-01) / 20 mL in 1 VIAL	Remodulin	United Therapeutics Corporation	2002-05-22
66302-0105-01	1 VIAL in 1 BOX (66302-105-01) / 20 mL in 1 VIAL	Remodulin	United Therapeutics Corporation	2002-05-22
66302-0110-01	1 VIAL in 1 BOX (66302-110-01) / 20 mL in 1 VIAL	Remodulin	United Therapeutics Corporation	2002-05-22
66302-0114-01	1 VIAL in 1 BOX (66302-114-01) / 20 mL in 1 VIAL	Remodulin	United Therapeutics Corporation	2023-09-28
66302-0150-50	1 VIAL in 1 BOX (66302-150-50) / 50 mL in 1 VIAL	Sterile Diluent for Remodulin	United Therapeutics Corporation	2014-12-22

Observed labelers: United Therapeutics Corporation (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J3285	Treprostinil injection	5	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.